Cargando…
Protection against invasive meningococcal disease and vaccination policy in the Netherlands
BACKGROUND: A rise in serogroup C invasive meningococcal disease (IMD-C) led to introduction of MenC vaccination in 2002 in the Netherlands at 14 months of age, accompanied by a mass-campaign for all children between 1 and 18 years (coverage 94%). Due to an IMD-W outbreak in 2016-17, the MenC vaccin...
Autores principales: | Ohm, M, Knol, M, Sanders, E, Berbers, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593912/ http://dx.doi.org/10.1093/eurpub/ckac130.098 |
Ejemplares similares
-
Strengthening Infectious Disease Control and Pandemic Preparedness in The Netherlands
por: Versteeg, S, et al.
Publicado: (2023) -
Determinants of COVID-19 vaccine uptake in the Netherlands: A nationwide registry-based study
por: Pijpers, J, et al.
Publicado: (2023) -
Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021) -
Vaccination policy strategies before and during the COVID-19 pandemic: an overview
por: Garlasco, J, et al.
Publicado: (2022) -
Fear of infection or fear of protection – driving factors of COVID-19 vaccine uptake in Bulgaria: Stanislava Hadzhieva
por: Rohova, M, et al.
Publicado: (2022)